Previous Close | 8.25 |
Open | 8.25 |
Bid | 6.00 |
Ask | 7.45 |
Strike | 35.00 |
Expire Date | 2026-12-18 |
Day's Range | 8.25 - 8.25 |
Contract Range | N/A |
Volume | |
Open Interest | 2.11k |
Cardiff Oncology Inc (CRDF) advances its clinical trials with promising results and maintains a strong cash position to support future growth.
Atea Pharmaceuticals Inc (AVIR) reports a robust cash runway into 2027 and significant progress in COVID-19 and HCV clinical trials.
NEW YORK, October 09, 2024--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the company’s common stock, payable December 2, 2024, to holders of the Common Stock of record at the close of business on November 8, 2024. The fourth-quarter 2024 cash dividend will be the 344th consecutive quarterly dividend paid by Pfizer.